US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NEWAMSTERDAM PHARMA CO NV

22.69

-0.1000-0.44%

Volume:680.86K

Turnover:15.32M

Market Cap:2.71B

PE:-10.58

High:22.91

Open:22.44

Low:21.96

Close:22.79

52wk High:42.21

52wk Low:21.96

Shares:119.54M

Float Shares:92.51M

Volume Ratio:2.20

T/O Rate:0.74%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1442

EPS(LYR):-1.7211

ROE:-36.81%

ROA:-20.11%

PB:4.30

PE(LYR):-13.18

Loading ...

Overview Company News Filings

NewAmsterdam Pharma joins Jefferies Global Healthcare Conference fireside chat

NewAmsterdam Pharma Chief Accounting Officer Louise Kooij reports $ 2.32 million share sale

Why NewAmsterdam Pharma (NAMS) Is Up 29.7% After Detailing Obicetrapib Phase 3 And Launch Milestones

Simply Wall St.

Stock Track | NewAmsterdam Pharma Soars 5.19% Intraday on Anticipation of Upcoming Conference Presentations

Analysts Conflicted on These Healthcare Names: Treace Medical Concepts (TMCI), NewAmsterdam Pharma Company (NAMS) and LENSAR (LNSR)

NewAmsterdam Pharma to present at BofA Securities Health Care Conference

Stock Track | NewAmsterdam Pharma Soars 5.31% Intraday on Guggenheim's Buy Rating

Wall Street Analysts Are Bullish on Top Healthcare Picks

Guggenheim Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)

NewAmsterdam Pharma Company NV reports results for the quarter ended March 31 - Earnings Summary

NewAmsterdam Pharma Q1 net loss widens to USD 48.4 million

Press Release: NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results

NewAmsterdam Pharma grants 50,400 inducement share options at $28.43 per share

NewAmsterdam Pharma Chief Accounting Officer Louise Kooij to depart Aug. 31

China National Investment & Guaranty Refutes Collaboration Claims with NAMS on Investment Products

NewAmsterdam Pharma announces annual shareholder meeting

A Look At NewAmsterdam Pharma (NAMS) Valuation After Positive Obicetrapib Trial Sentiment And ACC.26 Data Presentations

Simply Wall St.

NewAmsterdam Pharma grants 15,000 inducement options under Nasdaq Rule 5635(c)(4)

Will ACC.26 Obicetrapib Data on Kidney, Safety and Lipids Change NewAmsterdam Pharma's (NAMS) Narrative?

Simply Wall St.

NewAmsterdam Pharma published BROADWAY trial presentation; pooled BROADWAY and BROOKLYN analysis shows slower annualized eGFR decline on obicetrapib vs placebo

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/NAMS/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NAMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMS\",,,,,undefined,":{"symbol":"NAMS","market":"US","secType":"STK","nameCN":"NEWAMSTERDAM PHARMA CO NV","latestPrice":22.69,"timestamp":1789051265247,"preClose":22.79,"halted":0,"volume":680859,"delay":0,"changeRate":-0.004387889425186392,"floatShares":92512947,"shares":119537169,"eps":-2.144229,"marketStatus":"Trading","change":-0.1,"latestTime":"09-10 10:41:11 EDT","open":22.44,"high":22.91,"low":21.955,"amount":15319390.139028,"amplitude":0.041904,"askPrice":22.71,"askSize":17,"bidPrice":22.69,"bidSize":320,"shortable":0,"etf":0,"ttmEps":-2.144229,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":22.79,"preHourTrading":{"tag":"盘前","latestPrice":22.42,"preClose":22.79,"latestTime":"09:29 EDT","volume":5691,"amount":129479.139342,"timestamp":1789046999999,"change":-0.37,"changeRate":-0.016235,"amplitude":0.02545},"postHourTrading":{"tag":"盘后","latestPrice":23.1,"preClose":22.79,"latestTime":"19:56 EDT","volume":10263,"amount":234297.6671,"timestamp":1788998205672,"change":0.31,"changeRate":0.013602,"amplitude":0.021062},"volumeRatio":2.19767,"impliedVol":0.5938,"impliedVolPercentile":0.2311},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMS\",,,,,undefined,":{"symbol":"NAMS","floatShares":92512947,"roa":"-20.11%","roe":"-36.81%","lyrEps":-1.721092,"volumeRatio":2.19767,"shares":119537169,"dividePrice":0,"high":22.91,"amplitude":0.041904,"preClose":22.79,"low":21.955,"week52Low":21.955,"pbRate":"4.30","psRate":"380.89","week52High":42.205,"institutionHeld":0,"latestPrice":22.69,"committee":0.89911,"eps":-2.144229,"divideRate":0,"volume":680859,"delay":0,"ttmEps":-2.144229,"open":22.44,"prevYearClose":35.08,"prevWeekClose":25.4,"prevMonthClose":25.34,"prevQuarterClose":33.89,"fiveDayClose":25.59,"twentyDayClose":27.83,"sixtyDayClose":30.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAMS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"NAMS","fiscalQuarterEnding":"2026/06","expectedEps":-0.48,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2026-05-07","symbol":"NAMS","fiscalQuarterEnding":"2026/03","expectedEps":-0.46,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.4},{"date":"2026-02-18","symbol":"NAMS","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771405200000,"name":null,"time":"Pre-MKt","dateTimestamp":1771390800000,"actualEps":null},{"market":"US","date":"2025-11-05","symbol":"NAMS","fiscalQuarterEnding":"2025/09","expectedEps":-0.38,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.41},{"market":"US","date":"2025-08-06","symbol":"NAMS","fiscalQuarterEnding":"2025/06","expectedEps":-0.52,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":-0.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAMS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAMS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4118,"buy":0.5294,"hold":0.0588,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5294,"analysts":17,"updateTime":1784606400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NAMS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NAMS","date":"2026-09-09","current":-10.507273,"percent":0.491456,"low":-27.491906,"twenty":-20.874656,"median":-11.666484,"eighty":-4.993803,"high":37.547018,"avg":-10.466771,"sd":12.03193,"marketCap":3063737641},"quantilePoints":[{"date":"2021-09-10","current":-20.672351,"twenty":-20.952117,"median":-20.526525,"eighty":-20.273344,"marketCap":140578830},{"date":"2021-09-17","current":-20.788911,"twenty":-20.935877,"median":-20.538007,"eighty":-20.294251,"marketCap":140292810},{"date":"2021-09-24","current":-20.925132,"twenty":-20.932894,"median":-20.56006,"eighty":-20.301276,"marketCap":140864850},{"date":"2021-10-01","current":-21.007107,"twenty":-20.973142,"median":-20.575716,"eighty":-20.306471,"marketCap":140006790},{"date":"2021-10-08","current":-21.151111,"twenty":-21.00809,"median":-20.581853,"eighty":-20.310016,"marketCap":140721840},{"date":"2021-10-15","current":-20.992495,"twenty":-21.033503,"median":-20.614435,"eighty":-20.314138,"marketCap":140006790},{"date":"2021-10-22","current":-20.979254,"twenty":-21.015601,"median":-20.620294,"eighty":-20.319189,"marketCap":140292810},{"date":"2021-10-29","current":-21.103709,"twenty":-21.049534,"median":-20.628022,"eighty":-20.340912,"marketCap":140292810},{"date":"2021-11-05","current":-21.161406,"twenty":-21.059496,"median":-20.645111,"eighty":-20.350832,"marketCap":140578830},{"date":"2021-11-12","current":-21.337744,"twenty":-21.068902,"median":-20.670206,"eighty":-20.353037,"marketCap":140435820},{"date":"2021-11-19","current":-21.577137,"twenty":-21.091056,"median":-20.678231,"eighty":-20.353298,"marketCap":140435820},{"date":"2021-11-26","current":-21.52096,"twenty":-21.108578,"median":-20.693694,"eighty":-20.355018,"marketCap":140006790},{"date":"2021-12-03","current":-21.5525,"twenty":-21.125131,"median":-20.706276,"eighty":-20.35641,"marketCap":139863780},{"date":"2021-12-10","current":-21.569806,"twenty":-21.155229,"median":-20.729118,"eighty":-20.357488,"marketCap":140292810},{"date":"2021-12-17","current":-21.444455,"twenty":-21.18744,"median":-20.755321,"eighty":-20.360981,"marketCap":139005720},{"date":"2021-12-23","current":-21.411047,"twenty":-21.239434,"median":-20.778281,"eighty":-20.367381,"marketCap":139291740},{"date":"2021-12-31","current":-21.326314,"twenty":-21.328981,"median":-20.793694,"eighty":-20.376349,"marketCap":139434750},{"date":"2022-01-07","current":-21.496624,"twenty":-21.347524,"median":-20.831373,"eighty":-20.380063,"marketCap":140149800},{"date":"2022-01-14","current":-21.343042,"twenty":-21.350709,"median":-20.845796,"eighty":-20.384765,"marketCap":140149800},{"date":"2022-01-21","current":-21.439355,"twenty":-21.390606,"median":-20.871892,"eighty":-20.394177,"marketCap":139792275},{"date":"2022-01-28","current":-21.81807,"twenty":-21.411007,"median":-20.878577,"eighty":-20.407434,"marketCap":140006790},{"date":"2022-02-04","current":-21.195343,"twenty":-21.415476,"median":-20.901854,"eighty":-20.412214,"marketCap":139434750},{"date":"2022-02-11","current":-21.331112,"twenty":-21.429778,"median":-20.921405,"eighty":-20.419903,"marketCap":139863780},{"date":"2022-02-18","current":-21.489301,"twenty":-21.43906,"median":-20.931009,"eighty":-20.423447,"marketCap":140006790},{"date":"2022-02-25","current":-21.593859,"twenty":-21.452754,"median":-20.936467,"eighty":-20.427355,"marketCap":139863780},{"date":"2022-03-04","current":-22.31244,"twenty":-21.464918,"median":-20.972644,"eighty":-20.428933,"marketCap":140006790},{"date":"2022-03-11","current":-22.266973,"twenty":-21.496624,"median":-20.979146,"eighty":-20.432589,"marketCap":140149800},{"date":"2022-03-18","current":-22.060307,"twenty":-21.513575,"median":-20.987624,"eighty":-20.434714,"marketCap":140292810},{"date":"2022-03-25","current":-22.254443,"twenty":-21.52344,"median":-20.998804,"eighty":-20.447221,"marketCap":140578830},{"date":"2022-04-01","current":-22.154187,"twenty":-21.542769,"median":-21.012022,"eighty":-20.451813,"marketCap":140578830},{"date":"2022-04-08","current":-22.481854,"twenty":-21.567321,"median":-21.030475,"eighty":-20.452843,"marketCap":140578830},{"date":"2022-04-14","current":-22.67216,"twenty":-21.569768,"median":-21.052463,"eighty":-20.467141,"marketCap":140864850},{"date":"2022-04-22","current":-22.730966,"twenty":-21.579562,"median":-21.057477,"eighty":-20.474288,"marketCap":140864850},{"date":"2022-04-29","current":-23.274023,"twenty":-21.614609,"median":-21.067729,"eighty":-20.476303,"marketCap":141007860},{"date":"2022-05-06","current":-23.127906,"twenty":-21.66066,"median":-21.076365,"eighty":-20.478189,"marketCap":140864850},{"date":"2022-05-13","current":-23.491752,"twenty":-21.687663,"median":-21.09477,"eighty":-20.47859,"marketCap":140578830},{"date":"2022-05-20","current":-23.178757,"twenty":-21.820243,"median":-21.108122,"eighty":-20.48606,"marketCap":140578830},{"date":"2022-05-27","current":-22.893849,"twenty":-21.850993,"median":-21.120918,"eighty":-20.491024,"marketCap":141007860},{"date":"2022-06-03","current":-22.874754,"twenty":-21.920045,"median":-21.125878,"eighty":-20.495924,"marketCap":140950656},{"date":"2022-06-10","current":-23.37928,"twenty":-22.019208,"median":-21.131171,"eighty":-20.503856,"marketCap":141436890},{"date":"2022-06-17","current":-23.535903,"twenty":-22.073973,"median":-21.161634,"eighty":-20.508764,"marketCap":141579900},{"date":"2022-06-24","current":-23.228366,"twenty":-22.168168,"median":-21.177519,"eighty":-20.510788,"marketCap":140864850},{"date":"2022-07-01","current":-23.628446,"twenty":-22.205389,"median":-21.200156,"eighty":-20.514249,"marketCap":141293880},{"date":"2022-07-08","current":-24.122583,"twenty":-22.267227,"median":-21.212539,"eighty":-20.517301,"marketCap":141150870},{"date":"2022-07-15","current":-24.331277,"twenty":-22.320478,"median":-21.237179,"eighty":-20.518474,"marketCap":141150870},{"date":"2022-07-22","current":-24.090008,"twenty":-22.423227,"median":-21.257719,"eighty":-20.52015,"marketCap":141579900},{"date":"2022-07-29","current":-24.168576,"twenty":-22.534118,"median":-21.31615,"eighty":-20.524441,"marketCap":141722910},{"date":"2022-08-05","current":-4.879205,"twenty":-22.582014,"median":-21.326314,"eighty":-20.52015,"marketCap":141722910},{"date":"2022-08-12","current":-4.837995,"twenty":-22.549115,"median":-21.276097,"eighty":-20.510261,"marketCap":141865920},{"date":"2022-08-19","current":-4.945659,"twenty":-22.534118,"median":-21.248455,"eighty":-20.488701,"marketCap":142008930},{"date":"2022-08-26","current":-4.973006,"twenty":-22.502765,"median":-21.218542,"eighty":-20.475462,"marketCap":142151940},{"date":"2022-09-02","current":-4.964584,"twenty":-22.470606,"median":-21.200156,"eighty":-20.448139,"marketCap":142437960},{"date":"2022-09-09","current":-4.95567,"twenty":-22.425612,"median":-21.178962,"eighty":-20.428933,"marketCap":142296380},{"date":"2022-09-16","current":-4.974555,"twenty":-22.424465,"median":-21.161634,"eighty":-20.410452,"marketCap":142580970},{"date":"2022-09-23","current":-5.117324,"twenty":-22.418277,"median":-21.131171,"eighty":-20.379723,"marketCap":142294950},{"date":"2022-09-30","current":-5.084236,"twenty":-22.409269,"median":-21.125878,"eighty":-20.356574,"marketCap":142580970},{"date":"2022-10-07","current":-5.099691,"twenty":-22.388089,"median":-21.120336,"eighty":-20.35202,"marketCap":142580970},{"date":"2022-10-14","current":-5.125907,"twenty":-22.322487,"median":-21.105916,"eighty":-20.310612,"marketCap":142866990},{"date":"2022-10-21","current":4.123596,"twenty":-22.31244,"median":-21.088579,"eighty":-20.274813,"marketCap":143153010},{"date":"2022-10-28","current":4.07957,"twenty":-22.287254,"median":-21.074661,"eighty":-20.256213,"marketCap":143582040},{"date":"2022-11-04","current":4.09622,"twenty":-22.281341,"median":-21.06757,"eighty":-20.156594,"marketCap":143725050},{"date":"2022-11-11","current":3.835525,"twenty":-22.267291,"median":-21.05741,"eighty":-20.116823,"marketCap":140221305},{"date":"2022-11-18","current":3.965158,"twenty":-22.266973,"median":-21.047582,"eighty":-20.01593,"marketCap":145441170},{"date":"2022-11-25","current":22.070496,"twenty":-22.256949,"median":-21.02751,"eighty":-19.909786,"marketCap":812319096},{"date":"2022-12-02","current":18.678955,"twenty":-22.224077,"median":-21.009565,"eighty":-9.20741,"marketCap":693258130},{"date":"2022-12-09","current":20.55276,"twenty":-22.194292,"median":-20.992495,"eighty":-9.076373,"marketCap":766661932},{"date":"2022-12-16","current":23.284761,"twenty":-22.183606,"median":-20.985866,"eighty":-5.170387,"marketCap":873913042},{"date":"2022-12-23","current":24.514364,"twenty":-22.180369,"median":-20.979037,"eighty":-5.136784,"marketCap":921625514},{"date":"2022-12-30","current":23.500927,"twenty":-22.176953,"median":-20.972644,"eighty":-5.116761,"marketCap":889001602},{"date":"2023-01-06","current":25.713628,"twenty":-22.168168,"median":-20.939833,"eighty":-5.097544,"marketCap":965994034},{"date":"2023-01-13","current":21.766355,"twenty":-22.156426,"median":-20.931009,"eighty":-5.061828,"marketCap":833540951},{"date":"2023-01-20","current":21.475872,"twenty":-22.142244,"median":-20.923268,"eighty":-5.030111,"marketCap":823753778},{"date":"2023-01-27","current":34.556535,"twenty":-22.087638,"median":-20.91043,"eighty":-4.995999,"marketCap":1327793218},{"date":"2023-02-03","current":27.072439,"twenty":-22.055719,"median":-20.885889,"eighty":-4.981646,"marketCap":1039887195},{"date":"2023-02-10","current":27.186532,"twenty":-22.037344,"median":-20.873676,"eighty":-4.977626,"marketCap":1027653228},{"date":"2023-02-17","current":28.847843,"twenty":-22.035695,"median":-20.845796,"eighty":-4.96732,"marketCap":1088823063},{"date":"2023-02-24","current":29.876152,"twenty":-22.029478,"median":-20.834633,"eighty":-4.95567,"marketCap":1115737790},{"date":"2023-03-03","current":27.302811,"twenty":-22.012361,"median":-20.798477,"eighty":-4.893553,"marketCap":1024390836},{"date":"2023-03-10","current":28.150355,"twenty":-21.957814,"median":-20.782106,"eighty":-4.871727,"marketCap":1062723933},{"date":"2023-03-17","current":28.619298,"twenty":-21.954448,"median":-20.755321,"eighty":-4.837995,"marketCap":1079851487},{"date":"2023-03-24","current":29.32388,"twenty":-21.934194,"median":-20.729118,"eighty":3.771219,"marketCap":1116553388},{"date":"2023-03-31","current":-12.752993,"twenty":-21.910612,"median":-20.706276,"eighty":3.835525,"marketCap":1081482682},{"date":"2023-04-06","current":-12.88881,"twenty":-21.90985,"median":-20.697321,"eighty":3.835227,"marketCap":1098610236},{"date":"2023-04-14","current":-12.801571,"twenty":-21.899263,"median":-20.678231,"eighty":3.825059,"marketCap":1104319421},{"date":"2023-04-21","current":-14.947443,"twenty":-21.850993,"median":-20.670206,"eighty":3.781482,"marketCap":1279672948},{"date":"2023-04-28","current":-13.55748,"twenty":-21.838695,"median":-20.645111,"eighty":3.746421,"marketCap":1166304854},{"date":"2023-05-05","current":-13.247519,"twenty":-21.837737,"median":-20.628022,"eighty":-3.085842,"marketCap":1137758931},{"date":"2023-05-12","current":-13.196444,"twenty":-21.830658,"median":-20.620294,"eighty":-4.801486,"marketCap":1124709366},{"date":"2023-05-19","current":-11.577513,"twenty":-21.820243,"median":-20.614435,"eighty":-4.83115,"marketCap":973024741},{"date":"2023-05-26","current":-12.873913,"twenty":-21.775441,"median":-20.581853,"eighty":-4.843609,"marketCap":1077686226},{"date":"2023-06-02","current":-13.4553,"twenty":-21.758764,"median":-20.576071,"eighty":-4.84735,"marketCap":1127563965},{"date":"2023-06-09","current":-11.336689,"twenty":-21.717141,"median":-20.565455,"eighty":-4.85482,"marketCap":953400713},{"date":"2023-06-16","current":-11.670779,"twenty":-21.688764,"median":-20.543917,"eighty":-4.866541,"marketCap":995114272},{"date":"2023-06-23","current":-11.565622,"twenty":-21.678904,"median":-20.533873,"eighty":-4.872917,"marketCap":989390525},{"date":"2023-06-30","current":-11.66219,"twenty":-21.66693,"median":-20.521238,"eighty":-4.875603,"marketCap":991025881},{"date":"2023-07-07","current":-11.380237,"twenty":-21.664978,"median":-20.517651,"eighty":-4.879205,"marketCap":964860181},{"date":"2023-07-14","current":-11.034638,"twenty":-21.662538,"median":-20.509733,"eighty":-4.882597,"marketCap":964042503},{"date":"2023-07-21","current":-11.170865,"twenty":-21.660191,"median":-20.495236,"eighty":-4.893553,"marketCap":971810445},{"date":"2023-07-28","current":-11.009662,"twenty":-21.656236,"median":-20.47859,"eighty":-4.916273,"marketCap":944418228},{"date":"2023-08-04","current":-10.763767,"twenty":-21.630704,"median":-20.475882,"eighty":-4.940196,"marketCap":919887885},{"date":"2023-08-11","current":-3.964027,"twenty":-21.619037,"median":-20.452843,"eighty":-4.879205,"marketCap":906805035},{"date":"2023-08-18","current":-4.026987,"twenty":-21.613502,"median":-20.440967,"eighty":-4.848908,"marketCap":909683857},{"date":"2023-08-25","current":-4.022548,"twenty":-21.606196,"median":-20.428933,"eighty":-4.792358,"marketCap":904744397},{"date":"2023-09-01","current":-3.768342,"twenty":-21.593859,"median":-20.420865,"eighty":-4.019699,"marketCap":848763852},{"date":"2023-09-08","current":-3.73793,"twenty":-21.590181,"median":-20.408566,"eighty":-4.001992,"marketCap":830652499},{"date":"2023-09-15","current":-3.712765,"twenty":-21.579562,"median":-20.380574,"eighty":-3.942259,"marketCap":822420066},{"date":"2023-09-22","current":-3.650753,"twenty":-21.575135,"median":-20.368501,"eighty":-3.858715,"marketCap":808424930},{"date":"2023-09-29","current":-3.421608,"twenty":-21.572125,"median":-20.356574,"eighty":-3.838428,"marketCap":750797898},{"date":"2023-10-06","current":-3.012194,"twenty":-21.570144,"median":-20.353296,"eighty":-3.76226,"marketCap":658594648},{"date":"2023-10-13","current":-2.686479,"twenty":-21.569768,"median":-20.346082,"eighty":-3.707338,"marketCap":588618966},{"date":"2023-10-20","current":-2.811146,"twenty":-21.56948,"median":-20.312815,"eighty":-3.654052,"marketCap":617432482},{"date":"2023-10-27","current":-2.375367,"twenty":-21.568992,"median":-20.309123,"eighty":-3.646351,"marketCap":519466528},{"date":"2023-11-03","current":-3.917302,"twenty":-21.567321,"median":-20.299111,"eighty":-3.544741,"marketCap":863582232},{"date":"2023-11-10","current":-3.597007,"twenty":-21.566303,"median":-20.266499,"eighty":-3.604286,"marketCap":800192497},{"date":"2023-11-17","current":-3.627589,"twenty":-21.562197,"median":-20.256213,"eighty":-3.537462,"marketCap":818303850},{"date":"2023-11-24","current":-3.529793,"twenty":-21.562057,"median":-20.239654,"eighty":-3.489083,"marketCap":799369254},{"date":"2023-12-01","current":-3.547582,"twenty":-21.5525,"median":-20.141357,"eighty":-3.52171,"marketCap":803485470},{"date":"2023-12-08","current":-3.307014,"twenty":-21.542769,"median":-20.122709,"eighty":-3.489083,"marketCap":740918979},{"date":"2023-12-15","current":-3.69562,"twenty":-21.533656,"median":-20.083807,"eighty":-3.52171,"marketCap":843824392},{"date":"2023-12-22","current":-4.035423,"twenty":-21.527619,"median":-20.01593,"eighty":-3.522576,"marketCap":921209263},{"date":"2023-12-29","current":-4.090708,"twenty":-21.52655,"median":-19.978248,"eighty":-3.526906,"marketCap":940967103},{"date":"2024-01-05","current":-4.344468,"twenty":-21.525358,"median":-19.920067,"eighty":-3.533351,"marketCap":988715215},{"date":"2024-01-12","current":-6.195434,"twenty":-21.52344,"median":-19.753335,"eighty":-3.548025,"marketCap":1408569303},{"date":"2024-01-19","current":-6.4217,"twenty":-21.52344,"median":-15.556029,"eighty":-3.549796,"marketCap":1448908225},{"date":"2024-01-26","current":-8.782403,"twenty":-21.52096,"median":-14.109091,"eighty":-3.557352,"marketCap":1976607187},{"date":"2024-02-02","current":-7.600825,"twenty":-21.513689,"median":-13.749102,"eighty":-3.569428,"marketCap":1712346084},{"date":"2024-02-09","current":-7.207212,"twenty":-21.513575,"median":-13.613957,"eighty":-3.588398,"marketCap":1611087157},{"date":"2024-02-16","current":-7.247938,"twenty":-21.506276,"median":-13.555523,"eighty":-3.597007,"marketCap":1619319590},{"date":"2024-02-23","current":-8.32854,"twenty":-21.504386,"median":-13.501613,"eighty":-3.6123,"marketCap":1870809159},{"date":"2024-03-01","current":-11.523207,"twenty":-21.501535,"median":-13.4553,"eighty":-3.617449,"marketCap":2038881713},{"date":"2024-03-08","current":-10.554531,"twenty":-21.497487,"median":-13.312518,"eighty":-3.621659,"marketCap":1867487103},{"date":"2024-03-15","current":-11.064095,"twenty":-21.496624,"median":-13.247519,"eighty":-3.626597,"marketCap":1957647810},{"date":"2024-03-22","current":-11.326445,"twenty":-21.490766,"median":-13.177305,"eighty":-3.630464,"marketCap":2004067183},{"date":"2024-03-28","current":-11.452575,"twenty":-21.477499,"median":-13.148196,"eighty":-3.631217,"marketCap":2026384190},{"date":"2024-04-05","current":-10.801745,"twenty":-21.466803,"median":-12.946408,"eighty":-3.632099,"marketCap":1911228436},{"date":"2024-04-12","current":-10.055058,"twenty":-21.461539,"median":-12.894895,"eighty":-3.633023,"marketCap":1779111758},{"date":"2024-04-19","current":-9.807844,"twenty":-21.456824,"median":-12.873913,"eighty":-3.633343,"marketCap":1735370425},{"date":"2024-04-26","current":-10.816881,"twenty":-21.455182,"median":-12.8124,"eighty":-3.637723,"marketCap":1913906477},{"date":"2024-05-03","current":-11.469203,"twenty":-21.453725,"median":-12.730824,"eighty":-3.642957,"marketCap":2029326298},{"date":"2024-05-10","current":-8.594704,"twenty":-21.447775,"median":-12.51454,"eighty":-3.64496,"marketCap":1965488386},{"date":"2024-05-17","current":-7.883065,"twenty":-21.443062,"median":-12.154706,"eighty":-3.648552,"marketCap":1802746667},{"date":"2024-05-24","current":-7.51567,"twenty":-21.440467,"median":-11.944691,"eighty":-3.653227,"marketCap":1718728474},{"date":"2024-05-31","current":-7.287445,"twenty":-21.438765,"median":-11.913972,"eighty":-3.657432,"marketCap":1666536719},{"date":"2024-06-07","current":-7.712415,"twenty":-21.436028,"median":-11.820873,"eighty":-3.667469,"marketCap":1763721366},{"date":"2024-06-14","current":-7.649457,"twenty":-21.431796,"median":-11.712329,"eighty":-3.679697,"marketCap":1749323640},{"date":"2024-06-21","current":-6.779842,"twenty":-21.425982,"median":-11.674804,"eighty":-3.69138,"marketCap":1550455058},{"date":"2024-06-28","current":-7.688806,"twenty":-21.424034,"median":-11.670779,"eighty":-3.693076,"marketCap":1758322219},{"date":"2024-07-05","current":-7.869811,"twenty":-21.420068,"median":-11.629156,"eighty":-3.69699,"marketCap":1799715680},{"date":"2024-07-12","current":-8.259367,"twenty":-21.415476,"median":-11.571568,"eighty":-3.704241,"marketCap":1888801606},{"date":"2024-07-15","current":-7.818658,"twenty":-21.415058,"median":-11.565622,"eighty":-3.706013,"marketCap":1788017528},{"date":"2024-08-02","current":-6.78968,"twenty":-21.414641,"median":-11.56183,"eighty":-3.707784,"marketCap":1552704702},{"date":"2024-08-09","current":-6.633158,"twenty":-21.412151,"median":-11.523207,"eighty":-3.71219,"marketCap":1521659607},{"date":"2024-08-16","current":-6.431294,"twenty":-21.410928,"median":-11.485219,"eighty":-3.714995,"marketCap":1475351701},{"date":"2024-08-23","current":-6.486229,"twenty":-21.403699,"median":-11.452575,"eighty":-3.729351,"marketCap":1487953851},{"date":"2024-08-30","current":-6.3175,"twenty":-21.396025,"median":-11.40917,"eighty":-3.756177,"marketCap":1449247247},{"date":"2024-09-06","current":-6.35674,"twenty":-21.393924,"median":-11.355092,"eighty":-3.77086,"marketCap":1458248783},{"date":"2024-09-13","current":-6.278261,"twenty":-21.387534,"median":-11.326445,"eighty":-3.775122,"marketCap":1440245712},{"date":"2024-09-20","current":-6.301805,"twenty":-21.376871,"median":-11.275775,"eighty":-3.783142,"marketCap":1445646633},{"date":"2024-09-27","current":-6.211555,"twenty":-21.365168,"median":-11.250767,"eighty":-3.799975,"marketCap":1424943101},{"date":"2024-10-04","current":-6.894316,"twenty":-21.350709,"median":-11.235632,"eighty":-3.813963,"marketCap":1581569822},{"date":"2024-10-11","current":-6.913935,"twenty":-21.347524,"median":-11.180631,"eighty":-3.822859,"marketCap":1586070590},{"date":"2024-10-18","current":-7.467207,"twenty":-21.343075,"median":-11.167175,"eighty":-3.825993,"marketCap":1712992243},{"date":"2024-10-25","current":-7.400501,"twenty":-21.342938,"median":-11.154909,"eighty":-3.828323,"marketCap":1697689633},{"date":"2024-10-31","current":-7.063044,"twenty":-21.342346,"median":-11.153652,"eighty":-3.831162,"marketCap":1620276426},{"date":"2024-11-08","current":-10.245268,"twenty":-21.340032,"median":-11.119592,"eighty":-3.843127,"marketCap":2037947682},{"date":"2024-11-15","current":-11.597233,"twenty":-21.336418,"median":-11.153652,"eighty":-3.852751,"marketCap":2306875223},{"date":"2024-11-22","current":-9.344667,"twenty":-21.331041,"median":-11.139145,"eighty":-3.855094,"marketCap":1858803744},{"date":"2024-11-29","current":-9.219266,"twenty":-21.330759,"median":-11.119592,"eighty":-3.856223,"marketCap":1833859559},{"date":"2024-12-06","current":-8.392551,"twenty":-21.326314,"median":-11.114547,"eighty":-3.859338,"marketCap":1669412707},{"date":"2024-12-13","current":-11.652967,"twenty":-21.305987,"median":-11.115575,"eighty":-3.87719,"marketCap":2317961528},{"date":"2024-12-20","current":-11.824812,"twenty":-21.294475,"median":-11.119592,"eighty":-3.877993,"marketCap":2352144301},{"date":"2024-12-27","current":-12.182436,"twenty":-21.26507,"median":-11.153652,"eighty":-3.894887,"marketCap":2423281422},{"date":"2025-01-03","current":-13.971232,"twenty":-21.256167,"median":-11.154909,"eighty":-3.910026,"marketCap":2779101565},{"date":"2025-01-10","current":-13.750577,"twenty":-21.252461,"median":-11.164306,"eighty":-3.918163,"marketCap":2735209745},{"date":"2025-01-17","current":-12.604247,"twenty":-21.239434,"median":-11.175748,"eighty":-3.920305,"marketCap":2507186388},{"date":"2025-01-24","current":-12.485847,"twenty":-21.225631,"median":-11.191789,"eighty":-3.922976,"marketCap":2483634680},{"date":"2025-01-31","current":-11.716245,"twenty":-21.222143,"median":-11.235632,"eighty":-3.931982,"marketCap":2330548577},{"date":"2025-02-07","current":-11.355662,"twenty":-21.212096,"median":-11.250762,"eighty":-3.948487,"marketCap":2258822920},{"date":"2025-02-14","current":-10.440751,"twenty":-21.20829,"median":-11.235632,"eighty":-3.960565,"marketCap":2076832448},{"date":"2025-02-21","current":-10.225478,"twenty":-21.200156,"median":-11.183444,"eighty":-3.964027,"marketCap":2034011161},{"date":"2025-02-28","current":-9.504592,"twenty":-21.195343,"median":-11.175748,"eighty":-3.98226,"marketCap":2296290448},{"date":"2025-03-07","current":-10.681871,"twenty":-21.178962,"median":-11.164306,"eighty":-3.997428,"marketCap":2580718582},{"date":"2025-03-14","current":-10.718234,"twenty":-21.176077,"median":-11.154835,"eighty":-4.003133,"marketCap":2589504006},{"date":"2025-03-21","current":-10.940963,"twenty":-21.161863,"median":-11.124637,"eighty":-4.016201,"marketCap":2643314734},{"date":"2025-03-28","current":-10.186414,"twenty":-21.161406,"median":-11.118097,"eighty":-4.018359,"marketCap":2461017166},{"date":"2025-04-04","current":-8.181858,"twenty":-21.151111,"median":-11.108408,"eighty":-4.019699,"marketCap":1976720616},{"date":"2025-04-11","current":-6.772761,"twenty":-21.131171,"median":-11.085541,"eighty":-4.022548,"marketCap":1636285398},{"date":"2025-04-17","current":-7.286399,"twenty":-21.131171,"median":-11.049366,"eighty":-4.026099,"marketCap":1760379526},{"date":"2025-04-25","current":-7.940948,"twenty":-21.129921,"median":-11.009301,"eighty":-4.031104,"marketCap":1918517175},{"date":"2025-05-02","current":-9.10459,"twenty":-21.123639,"median":-10.998302,"eighty":-4.034765,"marketCap":2199650774},{"date":"2025-05-09","current":-11.536892,"twenty":-21.121629,"median":-10.997201,"eighty":-4.055194,"marketCap":2161528945},{"date":"2025-05-16","current":-11.205615,"twenty":-21.120569,"median":-10.998302,"eighty":-4.084594,"marketCap":2099461659},{"date":"2025-05-23","current":-10.953938,"twenty":-21.111476,"median":-11.006409,"eighty":-4.290374,"marketCap":2052307975},{"date":"2025-05-30","current":-10.564438,"twenty":-21.108578,"median":-10.998097,"eighty":-4.342797,"marketCap":1979332035},{"date":"2025-06-06","current":-11.690992,"twenty":-21.105474,"median":-11.002458,"eighty":-4.35749,"marketCap":2190400908},{"date":"2025-06-13","current":-12.601823,"twenty":-21.102061,"median":-11.009662,"eighty":-4.386985,"marketCap":2361052337},{"date":"2025-06-20","current":-10.906,"twenty":-21.096009,"median":-11.034638,"eighty":-4.422768,"marketCap":2043326321},{"date":"2025-06-27","current":-11.055808,"twenty":-21.087156,"median":-11.017754,"eighty":-4.497549,"marketCap":2071393990},{"date":"2025-07-03","current":-11.894731,"twenty":-21.083291,"median":-11.017754,"eighty":-4.606816,"marketCap":2228572938},{"date":"2025-07-11","current":-13.195061,"twenty":-21.075684,"median":-11.055808,"eighty":-4.79464,"marketCap":2472200307},{"date":"2025-07-18","current":-13.171092,"twenty":-21.071944,"median":-11.081388,"eighty":-4.810613,"marketCap":2467709480},{"date":"2025-07-25","current":-14.016008,"twenty":-21.067824,"median":-11.091761,"eighty":-4.839398,"marketCap":2626011135},{"date":"2025-08-01","current":-13.069223,"twenty":-21.06562,"median":-11.111477,"eighty":-4.845791,"marketCap":2448623465},{"date":"2025-08-08","current":-15.555229,"twenty":-21.05775,"median":-11.119592,"eighty":-4.850879,"marketCap":2577734743},{"date":"2025-08-15","current":-17.10683,"twenty":-21.05745,"median":-11.126176,"eighty":-4.861355,"marketCap":2834858287},{"date":"2025-08-22","current":-16.610684,"twenty":-21.057344,"median":-11.154761,"eighty":-4.872322,"marketCap":2752639513},{"date":"2025-08-29","current":-16.277655,"twenty":-21.055392,"median":-11.163241,"eighty":-4.875603,"marketCap":2697451569},{"date":"2025-09-05","current":-17.439859,"twenty":-21.047582,"median":-11.170454,"eighty":-4.879205,"marketCap":2890046232},{"date":"2025-09-12","current":-18.078731,"twenty":-21.03344,"median":-11.181125,"eighty":-4.882597,"marketCap":2995916982},{"date":"2025-09-19","current":-18.167086,"twenty":-21.02751,"median":-11.201038,"eighty":-4.893553,"marketCap":3010558682},{"date":"2025-09-26","current":-17.868039,"twenty":-21.012624,"median":-11.225569,"eighty":-4.916273,"marketCap":2961002160},{"date":"2025-10-03","current":-20.865303,"twenty":-21.012022,"median":-11.235632,"eighty":-4.940196,"marketCap":3457693660},{"date":"2025-10-10","current":-22.4319,"twenty":-21.03344,"median":-11.250767,"eighty":-4.945659,"marketCap":3717302256},{"date":"2025-10-17","current":-24.786892,"twenty":-21.057477,"median":-11.275775,"eighty":-4.95567,"marketCap":4107559863},{"date":"2025-10-24","current":-24.661157,"twenty":-21.072958,"median":-11.313477,"eighty":-4.962071,"marketCap":4086723598},{"date":"2025-10-31","current":-26.316108,"twenty":-21.100962,"median":-11.330122,"eighty":-4.964584,"marketCap":4360973893},{"date":"2025-11-07","current":-18.875595,"twenty":-21.108122,"median":-11.343438,"eighty":-4.966514,"marketCap":4172884368},{"date":"2025-11-14","current":-18.680224,"twenty":-21.103709,"median":-11.369961,"eighty":-4.970546,"marketCap":4129693081},{"date":"2025-11-21","current":-19.341879,"twenty":-21.100962,"median":-11.403361,"eighty":-4.973006,"marketCap":4275967218},{"date":"2025-11-28","current":-21.18323,"twenty":-21.101511,"median":-11.425388,"eighty":-4.974245,"marketCap":4683040205},{"date":"2025-12-05","current":-18.387864,"twenty":-21.101511,"median":-11.450359,"eighty":-4.976938,"marketCap":4065060323},{"date":"2025-12-12","current":-18.551996,"twenty":-21.091056,"median":-11.462665,"eighty":-4.977903,"marketCap":4101345380},{"date":"2025-12-19","current":-17.387688,"twenty":-21.085733,"median":-11.47284,"eighty":-4.980017,"marketCap":3843948255},{"date":"2025-12-26","current":-18.285282,"twenty":-21.079828,"median":-11.497644,"eighty":-4.980806,"marketCap":4042382162},{"date":"2026-01-02","current":-17.992923,"twenty":-21.075002,"median":-11.504096,"eighty":-4.981179,"marketCap":3977749404},{"date":"2026-01-09","current":-18.362219,"twenty":-21.07093,"median":-11.523207,"eighty":-4.981835,"marketCap":4059390783},{"date":"2026-01-16","current":-16.325962,"twenty":-21.067761,"median":-11.540459,"eighty":-4.982647,"marketCap":3609229291},{"date":"2026-01-23","current":-17.854437,"twenty":-21.06562,"median":-11.56138,"eighty":-4.984708,"marketCap":3947133887},{"date":"2026-01-30","current":-16.125926,"twenty":-21.05775,"median":-11.577513,"eighty":-4.992071,"marketCap":3565006877},{"date":"2026-02-06","current":-16.443931,"twenty":-21.05745,"median":-11.596174,"eighty":-4.995999,"marketCap":3635309176},{"date":"2026-02-13","current":-17.880082,"twenty":-21.024533,"median":-11.596174,"eighty":-4.995999,"marketCap":3952803427},{"date":"2026-02-20","current":-19.534974,"twenty":-21.002589,"median":-11.596174,"eighty":-4.995999,"marketCap":3981598863},{"date":"2026-02-27","current":-19.337537,"twenty":-20.979211,"median":-11.596174,"eighty":-4.995999,"marketCap":3941357466},{"date":"2026-03-06","current":-17.00214,"twenty":-20.967512,"median":-11.596174,"eighty":-4.995999,"marketCap":3465359219},{"date":"2026-03-13","current":-16.821626,"twenty":-20.928367,"median":-11.596174,"eighty":-4.995999,"marketCap":3428567084},{"date":"2026-03-20","current":-17.182654,"twenty":-20.913737,"median":-11.596174,"eighty":-4.995999,"marketCap":3502151354},{"date":"2026-03-27","current":-17.628297,"twenty":-20.913737,"median":-11.596174,"eighty":-4.995999,"marketCap":3592981937},{"date":"2026-04-02","current":-18.508302,"twenty":-20.890277,"median":-11.596174,"eighty":-4.995999,"marketCap":3772343595},{"date":"2026-04-10","current":-19.78318,"twenty":-20.877597,"median":-11.596174,"eighty":-4.995999,"marketCap":4032188049},{"date":"2026-04-17","current":-18.728303,"twenty":-20.869146,"median":-11.596174,"eighty":-4.995999,"marketCap":3817184010},{"date":"2026-04-24","current":-17.74676,"twenty":-20.869146,"median":-11.596174,"eighty":-4.995999,"marketCap":3617126776},{"date":"2026-05-01","current":-16.110854,"twenty":-20.869146,"median":-11.596174,"eighty":-4.995999,"marketCap":3283698052},{"date":"2026-05-08","current":-19.659077,"twenty":-20.869146,"median":-11.596174,"eighty":-4.995999,"marketCap":4006893456},{"date":"2026-05-15","current":-19.932467,"twenty":-20.878577,"median":-11.596174,"eighty":-4.995999,"marketCap":4240293563},{"date":"2026-05-22","current":-19.640339,"twenty":-20.878577,"median":-11.596174,"eighty":-4.995999,"marketCap":4178148209},{"date":"2026-05-29","current":-19.464488,"twenty":-20.878577,"median":-11.597233,"eighty":-4.99438,"marketCap":4140738936},{"date":"2026-06-05","current":-17.95327,"twenty":-20.878577,"median":-11.661611,"eighty":-4.995999,"marketCap":3819252993},{"date":"2026-06-12","current":-16.628894,"twenty":-20.878577,"median":-11.682898,"eighty":-4.995999,"marketCap":3537514404},{"date":"2026-06-18","current":-16.568445,"twenty":-20.878577,"median":-11.682898,"eighty":-4.995999,"marketCap":3524654966},{"date":"2026-06-26","current":-17.436708,"twenty":-20.878577,"median":-11.674804,"eighty":-4.99438,"marketCap":3709363253},{"date":"2026-07-02","current":-19.327105,"twenty":-20.878577,"median":-11.674804,"eighty":-4.99438,"marketCap":4111512941},{"date":"2026-07-10","current":-19.739255,"twenty":-20.878577,"median":-11.674804,"eighty":-4.99438,"marketCap":4199190925},{"date":"2026-07-17","current":-17.063025,"twenty":-20.878577,"median":-11.674804,"eighty":-4.99438,"marketCap":3629868547},{"date":"2026-07-24","current":-16.788258,"twenty":-20.878577,"median":-11.674804,"eighty":-4.99438,"marketCap":3571416558},{"date":"2026-07-31","current":-15.639733,"twenty":-20.881502,"median":-11.672791,"eighty":-4.993803,"marketCap":3327087242},{"date":"2026-08-07","current":-12.465061,"twenty":-20.881502,"median":-11.672791,"eighty":-4.993803,"marketCap":3234733098},{"date":"2026-08-14","current":-12.285191,"twenty":-20.881502,"median":-11.672791,"eighty":-4.993803,"marketCap":3188056297},{"date":"2026-08-21","current":-12.796499,"twenty":-20.881502,"median":-11.672791,"eighty":-4.993803,"marketCap":3320742554},{"date":"2026-08-28","current":-12.340468,"twenty":-20.881502,"median":-11.672791,"eighty":-4.993803,"marketCap":3202400757},{"date":"2026-09-04","current":-11.907469,"twenty":-20.878577,"median":-11.666484,"eighty":-4.993803,"marketCap":3090035818},{"date":"2026-09-09","current":-11.806129,"twenty":-20.874656,"median":-11.666484,"eighty":-4.993803,"marketCap":3063737641}],"updateTime":1789048571404},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NAMS\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2638479698","title":"NewAmsterdam Pharma joins Jefferies Global Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2638479698","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638479698?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:05","pubTimestamp":1779969940,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma to present at the Jefferies Global Healthcare Conference in New York on June 3, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL7JslTp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443622.USD","LU2237443978.SGD","LU0345770993.USD","LU0061475181.USD","IE00B64PRP62.GBP","LU0742534661.SGD","LU1868836757.USD","SG9999014021.USD","IE0002270589.USD","LU1668664300.SGD","BK4550","LU0096364046.USD","LU1868837136.USD","LU0942090050.USD","IE0004091025.USD","IE0034235188.USD","BK4112","LU0251131958.USD","BK4552","IE00BGHQF748.EUR","BK4533","IE00BFXG1179.USD","IE00BSNM7G36.USD","LU0345770308.USD","LU0868494617.USD","LU1804176565.USD","LU2471134879.HKD","NAMS","LU2237443549.SGD","IE00BKPKM429.USD","NDAQ","LU0106831901.USD","IE00B3QW5Z07.USD","BK4585","LU1791807156.HKD","GSX","LU2471134796.USD","LU1868836914.USD","LU2210149790.SGD","LU1868837300.USD","LU0048573561.USD","IE00B19Z3581.USD","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","LU2471134523.USD","SG9999014039.USD","IE00BN0W2V16.EUR","LU0868494708.USD","BK4127","LU2471134952.CNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638369316","title":"NewAmsterdam Pharma Chief Accounting Officer Louise Kooij reports $ 2.32 million share sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2638369316","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638369316?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:31","pubTimestamp":1779913883,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Chief Accounting Officer Louise Frederika Kooij sold 65,000 ordinary shares at a weighted average price of $35.69.The sale followed option exercises for 65,000 shares at $10 and $10.9.She reported direct ownership of 24,353 ordinary shares following the transactions.The trades were executed under a Rule 10b5-1 plan adopted on Feb. 23, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL6hfbty:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"NewAmsterdam Pharma Chief Accounting Officer Louise Kooij reports $ 2.32 million share sale","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634382872","title":"Why NewAmsterdam Pharma (NAMS) Is Up 29.7% After Detailing Obicetrapib Phase 3 And Launch Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2634382872","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634382872?lang=en_us&edition=fundamental","pubTime":"2026-05-11 22:20","pubTimestamp":1778509250,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Company N.V. has reported first-quarter 2026 results, posting US$3.04 million in sales and a net loss of US$48.44 million, while outlining ongoing Phase 3 programs for its lead drug obicetrapib.\nInvestors also heard that an interim analysis of the PREVAIL cardiovascular outcomes trial is planned for late 2026, alongside pending European regulatory decisions and potential initial commercial launches of obicetrapib by Menarini.\nWe will now examine how the planned PREVAIL...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/why-newamsterdam-pharma-nams-is-up-297-after-detailing-obice","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/why-newamsterdam-pharma-nams-is-up-297-after-detailing-obice","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NAMS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133092420","title":"Stock Track | NewAmsterdam Pharma Soars 5.19% Intraday on Anticipation of Upcoming Conference Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=1133092420","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133092420?lang=en_us&edition=fundamental","pubTime":"2026-05-11 22:06","pubTimestamp":1778508375,"startTime":"0","endTime":"0","summary":"NEWAMSTERDAM PHARMA CO NV (NAMS) experienced a significant intraday surge, with its stock price soaring by 5.19%.The movement appears to be driven by investor optimism following the company's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NAMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634746282","title":"Analysts Conflicted on These Healthcare Names: Treace Medical Concepts (TMCI), NewAmsterdam Pharma Company (NAMS) and LENSAR (LNSR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634746282","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634746282?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:30","pubTimestamp":1778506224,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Treace Medical Concepts (TMCI), NewAmsterdam Pharma Company (NAMS...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-treace-medical-concepts-tmci-newamsterdam-pharma-company-nams-and-lensar-lnsr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-treace-medical-concepts-tmci-newamsterdam-pharma-company-nams-and-lensar-lnsr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4588","XLV","BK4139","LABU","BK4082","BK4539","TMCI","LU0029874061.USD","LU0128526141.USD","BK4585","HCSG","NAMS","LNSR","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634815682","title":"NewAmsterdam Pharma to present at BofA Securities Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2634815682","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634815682?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:41","pubTimestamp":1778503279,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma scheduled to present at BofA Securities 2026 Health Care Conference in Las Vegas on May 12, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL25yn75:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","LU1496350502.SGD","LU1668664300.SGD","LU1718418525.SGD","IE0001KFT4U8.USD","IE00B19Z3B42.SGD","BK4559","LU1894683348.USD","LU1162221912.USD","LU0130102774.USD","LU1035773651.USD","LU1894683264.USD","IE00BFXG1179.USD","IE00BGHQF748.EUR","LU1496350171.SGD","IE00B1BXHZ80.USD","LU0868494617.USD","IE00B7SZLL34.SGD","NDAQ","LU1069347547.HKD","IE00BKPKM429.USD","LU0256863811.USD","IE00B19Z3581.USD","BAC","BK4588","LU0203347892.USD","SG9999014039.USD","LU0971096721.USD","LU0070302665.USD","LU1363072403.SGD","IE00BN0W2W23.USD","LU0130103400.USD","LU0314104364.USD","LU1506573853.SGD","SG9999014013.SGD","BK4534","IE00BLSP4452.SGD","BK4553","LU0106831901.USD","NAMS","LU0128525689.USD","LU0130517989.USD","LU0306806265.USD","LU0306807586.USD","BK4139","LU0648001328.SGD","LU0477156953.USD","LU0980610538.SGD","LU0787776722.HKD","LU1280957306.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181913423","title":"Stock Track | NewAmsterdam Pharma Soars 5.31% Intraday on Guggenheim's Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1181913423","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181913423?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:49","pubTimestamp":1778248167,"startTime":"0","endTime":"0","summary":"NEWAMSTERDAM PHARMA CO NV (NAMS) saw its stock price soar 5.31% during intraday trading on Friday.The surge followed a positive analyst update from Guggenheim, where analyst Debjit Chattopadhyay...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NAMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633236454","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2633236454","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633236454?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:41","pubTimestamp":1778247676,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on NewAmsterdam Pharma Company (NAMS), Insmed (INSM) an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-155?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-155?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLSG","BK4137","NAMS","XBI","LU0889565916.HKD","LU0320765992.SGD","LU0128526141.USD","BK4139","LABU","INSM","LU0029874061.USD","BK4112","LU0053671581.USD","BK4588","BLSX","BK4581","LU0109394709.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633453245","title":"Guggenheim Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633453245","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633453245?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:39","pubTimestamp":1778240359,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Debjit Chattopadhyay maintained a Buy rating on NewAmsterdam Pharma Company yesterday and set a price target of $45.00. The comp...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-their-buy-rating-for-newamsterdam-pharma-company-nams-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-their-buy-rating-for-newamsterdam-pharma-company-nams-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633240781","title":"NewAmsterdam Pharma Company NV reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633240781","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633240781?lang=en_us&edition=fundamental","pubTime":"2026-05-08 00:33","pubTimestamp":1778171631,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Company NV reports results for the quarter ended March 31 - Earnings SummaryNewAmsterdam Pharma Company NV NAMS.OQ reported a quarterly adjusted loss of 40 cents per share for the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL8N41K2JA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NAMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633145616","title":"NewAmsterdam Pharma Q1 net loss widens to USD 48.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633145616","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633145616?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:03","pubTimestamp":1778151810,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma posted a net loss of USD 48.4 million in first-quarter 2026, worsening from a loss of USD 39.5 million a year earlier.Revenue held steady at USD 3 million, while operating loss narrowed to USD 58.4 million from USD 68.9 million.R&D expense fell to USD 38 million from USD 44.8 million, while SG&A costs dropped to USD 23.5 million from USD 27.2 million.Cash, cash equivalents and marketable securities totaled USD 707.3 million at March 31, down from USD 728.9 million at Dec. 31.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief on May 07, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDLcgF8mG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633455991","title":"Press Release: NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633455991","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633455991?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151600,"startTime":"0","endTime":"0","summary":"-- PREVAIL interim analysis planned for 4Q2026 with result expected in 1Q2027 --. -- Completed enrollment in REMBRANDT; Topline data from RUBENS Phase 3 expected by year-end 2026 --. -- Presented new analyses of Phase 3 BROOKLYN and BROADWAY studies at the American College of Cardiology Annual Scientific Session  and simultaneously published in the American Journal of Preventative Cardiology--. -- $707.3 million in cash, cash equivalents and marketable securities at March 31, 2026 --. -- Management to host PREVAIL update call today at 8:00 AM ET --. NewAmsterdam is developing obicetrapib, an oral, low-dose and once-daily, highly-selective cholesteryl ester transfer protein  inhibitor, as a monotherapy and in fixed-dose combination with ezetimibe, as the preferred LDL-C lowering therapy to be used in patients at risk of CVD for whom existing therapies are not sufficiently effective or well-tolerated.In March 2026, NewAmsterdam presented results from additional analyses of its pivotal Ph","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632640170","title":"NewAmsterdam Pharma grants 50,400 inducement share options at $28.43 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2632640170","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632640170?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:57","pubTimestamp":1777669050,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma granted inducement share options for 50,400 ordinary shares to five non-executive new hires on May 1, 2026.Option exercise price set at USD 28.43 per share.Options vest over four years, with 25% vesting at year one.Separate inducement restricted stock units for 15,400 ordinary shares were granted to five non-executive new hires on May 1, 2026.RSUs vest over three years in equal annual installments.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL2RHf0v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00B64PRP62.GBP","SG9999014039.USD","LU2095319765.USD","LU2210149790.SGD","NAMS","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","LU0314104364.USD","NDAQ","SG9999014005.SGD","IE00BKPKM429.USD","BK4585","SG9999014013.SGD","IE00BN0W2T93.GBP","BK4588","BK4112","BK4139","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630082761","title":"NewAmsterdam Pharma Chief Accounting Officer Louise Kooij to depart Aug. 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2630082761","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630082761?lang=en_us&edition=fundamental","pubTime":"2026-04-25 04:32","pubTimestamp":1777062734,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma set Aug. 31, 2026 as end date for Chief Accounting Officer Louise Kooij’s employment.Stock option and RSU vesting for Kooij extended through Jan. 10, 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 24, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDLzX2MW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NAMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190531077","title":"China National Investment & Guaranty Refutes Collaboration Claims with NAMS on Investment Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1190531077","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190531077?lang=en_us&edition=fundamental","pubTime":"2026-04-23 15:41","pubTimestamp":1776930089,"startTime":"0","endTime":"0","summary":"China National Investment & Guaranty (CNIG) issued a statement on April 23 clarifying recent fraudulent activities. The company reported that it has received information indicating that unauthorized...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NAMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628740764","title":"NewAmsterdam Pharma announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2628740764","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628740764?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:01","pubTimestamp":1776686517,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma set annual general meeting for June 2, 2026 in Amsterdam.Shareholders will vote on adoption of Dutch statutory annual accounts for fiscal year 2025.Ballot includes director discharge from liability for fiscal year 2025 actions.Items include auditor instruction, auditor ratification, reappointment of John W. Smither, reappointment of Janneke van der Kamp.Other votes cover share issuance authority, pre-emption rights exclusion authority, 2026 employee stock purchase plan, advisory approval of 2025 executive compensation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL2wB59Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625972646","title":"A Look At NewAmsterdam Pharma (NAMS) Valuation After Positive Obicetrapib Trial Sentiment And ACC.26 Data Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2625972646","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625972646?lang=en_us&edition=fundamental","pubTime":"2026-04-05 15:29","pubTimestamp":1775374185,"startTime":"0","endTime":"0","summary":"Event driven interest in NewAmsterdam Pharma\nNewAmsterdam Pharma (NasdaqGM:NAMS) is back on investors’ radar after an investor letter highlighted optimism around trial outcomes for its CETP inhibitor obicetrapib, supported by new data presentations at the ACC.26 cardiology conference.\nSee our latest analysis for NewAmsterdam Pharma.\nNewAmsterdam Pharma’s recent presentations around obicetrapib, combined with the investor letter, come as the share price sits at US$32.99, with strong recent...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/a-look-at-newamsterdam-pharma-nams-valuation-after-positive-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/a-look-at-newamsterdam-pharma-nams-valuation-after-positive-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NAMS","DCF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624868099","title":"NewAmsterdam Pharma grants 15,000 inducement options under Nasdaq Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624868099","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624868099?lang=en_us&edition=fundamental","pubTime":"2026-04-03 05:43","pubTimestamp":1775166234,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma granted inducement share options covering 15,000 ordinary shares to two non-executive new hires.Options carry an exercise price of $32.81 per share, set at April 1 closing price.Option awards vest over four years, with 25% vesting after one year.Company also issued restricted stock units covering 3,200 ordinary shares to two non-executive new hires.RSU awards vest over three years, with one-third vesting each year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL4vtrVW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","BK4585","IE00BGHQF748.EUR","BK4588","IE00B64PRP62.GBP","LU2210150020.SGD","SG9999014039.USD","IE00BKPKM429.USD","LU0314104364.USD","IE00BN0W2T93.GBP","NAMS","BK4139","SG9999014021.USD","BK4112","NDAQ","SG9999014005.SGD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","SG9999014013.SGD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623392305","title":"Will ACC.26 Obicetrapib Data on Kidney, Safety and Lipids Change NewAmsterdam Pharma's (NAMS) Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2623392305","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623392305?lang=en_us&edition=fundamental","pubTime":"2026-03-30 15:05","pubTimestamp":1774854330,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma announced it would present multiple Phase 3 and outcomes-related data sets for its oral CETP inhibitor obicetrapib at the ACC.26 cardiology meeting in New Orleans, highlighting kidney function, safety and lipid-related cardiovascular risk metrics in high‑risk patients.\nAn interesting angle for investors is that obicetrapib is being positioned as a low‑dose, oral option intended to complement or expand existing LDL‑lowering approaches, with European commercialization...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/will-acc26-obicetrapib-data-on-kidney-safety-and-lipids-chan","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/will-acc26-obicetrapib-data-on-kidney-safety-and-lipids-chan","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","NAMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622218851","title":"NewAmsterdam Pharma published BROADWAY trial presentation; pooled BROADWAY and BROOKLYN analysis shows slower annualized eGFR decline on obicetrapib vs placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2622218851","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622218851?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:15","pubTimestamp":1774523754,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma published BROADWAY trial presentation; pooled BROADWAY and BROOKLYN analysis shows slower annualized eGFR decline on obicetrapib vs placebo. NewAmsterdam Pharma published a medical research presentation titled “CETP Inhibition With Obicetrapib Preserved Kidney Function in Patients at High Cardiovascular Risk: Results From the BROADWAY Trial.”The document reports a post hoc pooled analysis from the phase 3 BROADWAY and BROOKLYN randomized, double-blind, placebo-controlled trials evaluating obicetrapib 10 mg as an adjunct to lipid-lowering therapy over 1 year.In the pooled analysis, annualized eGFR change was -0.41 mL/min/1.73 m2 per year with obicetrapib versus -1.08 with placebo.Composite renal events were reported in 1.9% of obicetrapib-treated participants versus 3.0% with placebo.The presentation states there was no significant difference between groups in annualized changes in urine albumin-to-creatinine ratio.Disclaimer: This news brief was created by Public Te","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL5K7MZJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":65,"code":"91000000","status":"200"}]}}